BDRX

BIODEXA PHARMACEUTICALS PLC ADR

BDRX·59564R880·US·ADR·Healthcare - Biotechnology-13D/G

BDRX (BIODEXA PHARMACEUTICALS PLC ADR) is held by 2 institutional investors as of Q1 2026. Largest holders: UBS Group AG ($78), RHUMBLINE ADVISERS ($11). Net institutional sentiment: Bearish.

2
Holders
Avg rating(1 Elite)
$89
Total Value
0% (3)
Fund Consensus
0 buying - 3 selling
BDRXSmart Money Verdict
View all
Held by 2 funds
1 elite
Who's Trading
ActivistARArmistice Capital, LLC10.0%May 15, 2026
ActivistARArmistice Capital, LLC10.0%Feb 17, 2026
ActivistSASABBY MANAGEMENT, LLC9.9%Jan 20, 2026
ActivistCICavalry Fund I LP0.0%Nov 14, 2025
ActivistCICavalry Fund I LP5.7%May 28, 2025

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used